Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1999 1
2004 2
2005 4
2006 1
2007 1
2008 1
2009 7
2010 2
2011 5
2012 7
2013 6
2014 4
2015 9
2016 3
2017 3
2018 4
2019 6
2020 2
2021 7
2022 7
2023 5
2024 10
2025 6
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer.
Strickler JH, Raimbourg J, Cohen JE, Ghiringhelli F, Sharma MR, Kitagawa C, Lee KH, O'Neil B, de Miguel M, Saada-Bouzid E, Li R, Rudra-Ganguly N, Luo A, Parikh A, Morrison-Thiele G, Neagu Aristide M, Hunter Z, Burns M, Kuboki Y. Strickler JH, et al. Among authors: kitagawa c. Clin Cancer Res. 2026 Jun 15;32(12):2352-2361. doi: 10.1158/1078-0432.CCR-25-3597. Clin Cancer Res. 2026. PMID: 41910595 Free PMC article. Clinical Trial.
Olanzapine for nausea and vomiting in people with breast cancer treated with trastuzumab deruxtecan: plain language summary of the ERICA study.
Sakai H, Tsurutani J, Ozaki Y, Ishiguro H, Nozawa K, Yamanaka T, Aogi K, Matsumoto K, Iwasa T, Tokiwa M, Tsuneizumi M, Miyoshi Y, Kitagawa C, Yamamoto M, Takano Y, Imamura CK, Chiba Y, Takiguchi D, Ezumi T, Takano T. Sakai H, et al. Among authors: kitagawa c. Future Oncol. 2025 Nov;21(27):3459-3475. doi: 10.1080/14796694.2025.2566329. Epub 2025 Oct 24. Future Oncol. 2025. PMID: 41132084 Free PMC article.
Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical Trial.
Kikawa Y, Uemura Y, Taira T, Kitagawa C, Maeda H, Kato H, Hashimoto N, Hosoda M, Hamanaka Y, Tanabe Y, Yoshida T, Tane K, Takabatake D, Ishikawa T, Iwamoto T, Yamaguchi T, Takiguchi D, Mukai H, Taira N, Sangai T. Kikawa Y, et al. Among authors: kitagawa c. JAMA Netw Open. 2025 Aug 1;8(8):e2527403. doi: 10.1001/jamanetworkopen.2025.27403. JAMA Netw Open. 2025. PMID: 40815510 Free PMC article. Clinical Trial.
Efficacy of Combined Dabrafenib and Trametinib Therapy in BRAFV600E Mutant Intrahepatic Cholangiocarcinoma with a Neurofibromatosis Type 2 Mutation.
Yoshida J, Sugiyama K, Owaki S, Ito T, Yamaguchi Y, Emi R, Sako Y, Satoh M, Ino R, Kato K, Shiraishi K, Shimada M, Hattori H, Kitagawa C. Yoshida J, et al. Among authors: kitagawa c. Intern Med. 2025 Nov 1;64(21):3107-3110. doi: 10.2169/internalmedicine.5141-24. Epub 2025 Apr 26. Intern Med. 2025. PMID: 40301031 Free PMC article.
A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancer.
Baba K, Suzuki N, Imamura CK, Booka E, Takeuchi M, Takahari D, Kawakami T, Kawakubo H, Kitagawa C, Kono Y, Ogura K, Kito Y, Saito K, Yamamoto S, Takeuchi H, Kudo T, Tsunoda T, Mizukami T, Yamaguchi T, Shoji H, Saito K, Tanoue K, Baba E, Nagashima K, Boku N. Baba K, et al. Among authors: kitagawa c. BMC Cancer. 2025 Apr 12;25(1):675. doi: 10.1186/s12885-025-14084-1. BMC Cancer. 2025. PMID: 40221699 Free PMC article. Clinical Trial.
100 results